SCHEMBL22909670

SCHEMBL22909670

Cc1cc(-n2nc3c(c2N)[C@H](C)N(C=O)[C@H](C)C3)cc(C)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21175421 1.00 — —
SCHEMBL26767863 0.80 — —
SCHEMBL21175176 0.79 GLP1R (0.32) —
SCHEMBL22909671 0.73 ALDH1A1 (0.33) —
SCHEMBL28952319 0.72 GLP1R (0.32) —
SCHEMBL21175252 0.72 GLP1R (0.32) —
SCHEMBL28952435 0.70 NR1H2 (0.33) —
SCHEMBL31692192 0.68 LMNA (0.34) —
SCHEMBL31692208 0.65 CHRM2 (0.34) —
SCHEMBL38651835 0.65 F12 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210017176-A1 PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2021-01-21 — — US disclosed
Send feedback